18278812

Source:http://linkedlifedata.com/resource/pubmed/id/18278812

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026764, umls-concept:C0087111, umls-concept:C0857496
pubmed:issue	7
pubmed:dateCreated	2008-3-25
pubmed:abstractText	The purpose was to evaluate the incidence and risk factors of thromboembolism associated with lenalidomide therapy in newly diagnosed myeloma.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA 100080, http://linkedlifedata.com/resource/pubmed/grant/CA 62242, http://linkedlifedata.com/resource/pubmed/grant/CA 93842, http://linkedlifedata.com/resource/pubmed/grant/CA107476, http://linkedlifedata.com/resource/pubmed/grant/P01 CA062242-130011, http://linkedlifedata.com/resource/pubmed/grant/R01 CA093842-03, http://linkedlifedata.com/resource/pubmed/grant/R01 CA100080-04, http://linkedlifedata.com/resource/pubmed/grant/R01 CA107476-05
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-10776741, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-10963215, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-11419443, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-12229885, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-12384400, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-12780791, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-12888931, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-15383478, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16118317, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16342649, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16350272, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16365178, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16687729, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16839339, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16840727, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16882132, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-16925483, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-17124082, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-17148721, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-17218586, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-5454323, http://linkedlifedata.com/resource/pubmed/commentcorrection/18278812-7987155
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Melphalan, http://linkedlifedata.com/resource/pubmed/chemical/Myeloablative Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide, http://linkedlifedata.com/resource/pubmed/chemical/lenalidomide
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0008-543X
pubmed:author	pubmed-author:FalcoPatriziaP, pubmed-author:LacyMarthaM, pubmed-author:MenonSmitha PatiyilSP, pubmed-author:PalumboAntonioA, pubmed-author:RajkumarS VincentSV
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	112
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1522-8
pubmed:dateRevised	2010-12-3
pubmed:meshHeading	pubmed-meshheading:18278812-Adult, pubmed-meshheading:18278812-Aged, pubmed-meshheading:18278812-Anti-Inflammatory Agents, pubmed-meshheading:18278812-Antineoplastic Agents, pubmed-meshheading:18278812-Dexamethasone, pubmed-meshheading:18278812-Drug Therapy, Combination, pubmed-meshheading:18278812-Female, pubmed-meshheading:18278812-Fibrinolytic Agents, pubmed-meshheading:18278812-Humans, pubmed-meshheading:18278812-Incidence, pubmed-meshheading:18278812-Male, pubmed-meshheading:18278812-Melphalan, pubmed-meshheading:18278812-Middle Aged, pubmed-meshheading:18278812-Multiple Myeloma, pubmed-meshheading:18278812-Myeloablative Agonists, pubmed-meshheading:18278812-Prednisone, pubmed-meshheading:18278812-Risk Factors, pubmed-meshheading:18278812-Survival Rate, pubmed-meshheading:18278812-Thalidomide, pubmed-meshheading:18278812-Venous Thrombosis
pubmed:year	2008
pubmed:articleTitle	Thromboembolic events with lenalidomide-based therapy for multiple myeloma.
pubmed:affiliation	Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural